Founded in 2014, Sweetch is a clinically validated mobile-health platform that utilizes artificial technology (AI) to significantly increase patients’ engagement and compliance with essential health promotion and chronic disease management recommendations through Just-in-Time Adaptive Intervention.
Sweetch Health, an Artificial Intelligence based platform for prediction, prevention and management of chronic diseases, has announced that healthcare pioneer Prof. David Nash, MD, MBA, Founding Dean Emeritus of the Jefferson College of Population Health has joined the Sweetch Advisory Board.
This morning, data science company IQVIA unveiled a partnership with EMIS Health, a Leeds-based primary care software provider, to enable GPs in England electronically ‘prescribe’ apps evaluated against NHS standards to patients.
Artificial Intelligence (AI) is finding its way in various industries and uplifting their service capabilities to a great extent. The healthcare industry is no exception to this.
Sweetch, the first AI digital therapeutics solution that helps predict, prevent and improve outcomes among people with diabetes is partnering with integrated health care system WellSpan Health.
A recent Johns Hopkins study found that prediabetic patients who used the interactive mobile coaching program Sweetch lost weight and increased physical activity. The study, published in JMIR, found that participant lost a mean 3.5 pounds and significantly improved weekly physical activity over the course of the three-month trial.
Sweetch, the mobile-health app that helps prevent and improve outcomes in diabetes by encouraging long-term behavioral change, today revealed the outcomes of its clinical trial conducted at Johns Hopkins University. Directed by the university’s Division of Endocrinology, Diabetes, & Metabolism, the study shows that using Sweetch significantly lowered A1C levels, a diabetes biomarker for blood […]
While the world tries to decide whether artificial intelligence is here to help us or hurt us, AI is quietly infiltrating our daily lives — from streaming recommendations to image recognition. And in health technology, AI is making a real difference to people across the world, saving lives in a multitude of ways.
Background: Prediabetes is a high-risk state for the future development of type 2 diabetes, which may be prevented through physical activity (PA), adherence to a healthy diet, and weight loss. Mobile health (mHealth) technology is a practical and cost-effective method of delivering diabetes prevention programs in a real-world setting.
Sweetch is an Artificial Intelligence-based platform aimed at reducing the risk and improving the outcomes of Metabolic Syndrome diseases – Diabetes, Pre-Diabetes, Hypertension, Pre-Hypertension, Obesity, and Hyperlipidemia. Below is our interview with Dana Chanan CEO at Sweetch: […]